Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | H1₹62.29Admitted-Finance PLOT NO 2117 A 2 PHASE II II G I D C VAPI GUJARAT INDIA 396195 | VAPI | VALSAD | GUJARAT | 396195 | ₹62.29 | H1 | Admitted-Finance |
| 2 | H2₹61.20Admitted-Finance | ₹61.20 | H2 | Admitted-Finance |
| 3 | H3₹58.50Admitted-Finance | ₹58.50 | H3 | Admitted-Finance |
| 4 | H4₹43.12Admitted-Finance | ₹43.12 | H4 | Admitted-Finance |
| 5 | Rejected-Technical | - | - | Rejected-Technical Technically non responsive. |
| Sl No | Description | Qty | Unit | MICRON PHARMACEUTICALS H1 | MYLAN LABORATORIES LIMITED H2 | J. DUNCAN HEALTHCARE PVT LTD H3 | EMCURE PHARMACEUTICALS LTD. H4 |
|---|---|---|---|---|---|---|---|
| 1.00ANTI TB DRUGS | |||||||
| 1.02 | Darunavir 600mg IP | 81,84,600 | Nos. | - | - | - | - |
| 1.03 | Ritonavir 100mg IP | 80,84,070 | Nos. | - | - | - | - |
Tender Value
₹47.8 Cr
EMD Value
₹6.5 L
Closing Date
10 Jan 2020, 3:00 pmClosed
DG and CEO
Central Medical Services Society, Pt. Uma Shankar Dikshit Marg, Teen Murti Marg, Chankayapuri, New Delhi
Procurement of ARV Drugs
2019_CMSS_529809_1
CMSS/PROC/2019-20/NACO/043
Open Tender
Drugs and Pharmaceutical Products
60 days
Central Medical Services Society Delhi
As per tender terms and conditions
2 documents required · 2 mandatory
₹0
₹6.5 L
Yes
Central Medical Services Society, Delhi
19 Mar 2020
23 Dec 2019
10 Jan 2020
23 Dec 2019
10 Jan 2020
1 Jan 2020
23 Dec 2019 - 30 Dec 2019
30 Dec 2019
ANTI TB DRUGS
Darunavir 600mg IP
Ritonavir 100mg IP
MYLAN LABORATORIES LIMITED
J. DUNCAN HEALTHCARE PVT LTD
EMCURE PHARMACEUTICALS LTD.
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.58 MB
TED043Final.pdf
Tender Documents • 3.31 MB
BOQ_554817.xls
BOQ • 0.28 MB
Download all tender documents and submit your bid